Comments
Shares of Indoco Remedies may come under pressure following it receiving three critical and four major observations from the UK-MHRA for its Goa factory. The United Kingdom - Medicines and Healthcare Products Regulatory Agency had inspected Indoco’s Goa manufacturing unit between March 14 and 16. The company is fully committed to respond to UK-MHRA at the earliest within the stipulated time, Indoco said in a statement to the stock exchanges.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.